Skip to main content
. Author manuscript; available in PMC: 2011 Aug 15.
Published in final edited form as: J Immunol. 2010 Jul 16;185(4):2200–2208. doi: 10.4049/jimmunol.1000332

FIGURE 6.

FIGURE 6

F-LSECs produce enhanced T cell proliferation in vivo. Mice were adoptively transferred with OT-I T cells (2 × 106) before receiving footpad immunization with LSEC. OVA257 (2 × 105) or mock immunized. At 96 h, ipsilateral popliteal lymph nodes were harvested and costained for CD8 and OVA tetramer. The fraction of OVA tetramer+ cells among all CD8+ cells (A), the total number of Ova tetramer+ cells (B), and their expression of CD44 (C) were determined by flow cytometry. Experiments were repeated three times using two to four mice per experiment. *p < 0.05.

HHS Vulnerability Disclosure